Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

By Franz DN, Belousova E, Sparagana S et al.

Double-blind, placebo-controlled, multicentre, registered NCT00789828